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Abstract
A 71-year-old woman was transported to our hospital due to traumatic bleeding, and an operation was
immediately performed for achieving hemostasis. We decided to perform Sonoclot®-guided blood transfusion.
When Sonoclot signatures had returned normal values, further bleeding did not occur. We experienced the first
case of traumatic bleeding managed effectively by using Sonoclot. We suggest that a Sonoclot analyzer may be
useful for the management of severe coagulopathy due to traumatic bleeding like ROTEM and TEG.
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Background
Appropriate management and treatment of fluid and
blood transfusion resuscitation for a case of massive
bleeding is difficult. The amount and type of transfusion
must usually be considered to estimate the degree of
surgical site bleeding. Sonoclot® analyzer is a device for
point-of-care monitoring of blood coagulation [1]. It can
mainly show three signatures [2]: activated coagulation
time (SonACT), degree of fibrin formation (clot rate
(CR)), and ability of the clot retraction (platelet function
(PF)), all of which can be measured within about 20 min
[3]. We could manage effectively for a case of hemotho-
rax due to traumatic bleeding by using Sonoclot.
Case presentation
A 71-year-old woman (weight, 86 kg; height, 158 cm;
blood type, type A) was transported to another hospital
for hemodynamic unstability due to trauma. She was
suspected of having right hemothorax at that time. Thus,
she was immediately transported to the Department of
Emergency Medicine, Advanced Critical Care and Emer-
gency Center Care Unit in Sapporo Medical University
Hospital. Although she had severe hypotension (about
40 mmHg) during the transportation by ambulance, blood
pressure at admission to our hospital was 74/45 mmHg,
heart rate was 86 bpm, arterial saturation by oxygen inhal-
ation (10 L/min mask) was 95 %, and Glasgow Coma
Scale was 12. She was intubated and central venous
catheterization was performed. She was then immediately
admitted to operating room. Laboratory data before ad-
mission to the operating room showed severe coagulation
disorders as follows (Table 1): hemoglobin was 15.9 g/dL,
platelet count was 26,000/μL, international normalized
ratio of prothrombin time (PT-INR) was 1.6, activated
partial thromboplastin time (APTT) was 59.3 s, and fi-
brinogen was 65 mg/dL. Blood pressure at admission to
operating room was 66/36 mmHg, heart rate was 77 bpm,
arterial saturation was 100 %, and body temperature was
36.0°. During the operation, the amount of bleeding after
2 h exceeded 7000 mL. Thus, we considered the necessity
for point-of-care monitoring of blood coagulation for ap-
propriate transfusion. We decided to perform Sonoclot-
guided transfusion. The first data (Table 2) were obtained
at 2 h after starting the operation. The first data were as
follows (point 1): SonACT was 581 s, CR was 1.5, and PF
was 0.5. Thus, we continued to perform massive transfu-
sion. The amounts of red blood cells (RBC), fresh frozen
products (FFP), and platelets at that time were 28, 28, and
20 units, respectively. Although the degree of bleeding
gradually decreased, the amount of bleeding reached
9000 mL. The second Sonoclot signature (point 2) showed
that SonACT was 258 s, CR was 6.5, and PF was 0.5.
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Thus, we mainly performed transfusion of FFP and plate-
lets. We measured the Sonoclot signature again (point 3)
since bleeding from the surgical site had almost stopped.
SonACT was 193 s, CR was 11.3 (normal range), and PF
was 3.2 (normal range). We therefore did not perform
additional transfusion. The bleeding was diminished, and
the operation was soon finished. Total bleeding was
9680 mL, and total amounts of RBC, FFP, and platelets
transfused were 36, 46, and 40 units, respectively. The
cell-salvaged blood was also transfused 2750 mL. Labora-
tory data after the operation were as follows: hemoglobin
was 6.7 g/dL, platelet count was 74,000/μL, PT-INR was
1.31, APTT was 52.5 s, and fibrinogen was 136 mg/dL.
Blood pressure at operation finished was 116/59 mmHg,
heart rate was 77 bpm, arterial saturation was 100 %, and
body temperature was 35.6°. She was transported to the
Advanced Critical Care and Emergency Center Care Unit,
but further bleeding did not occur and she gradually
recovered.
Discussion
We experienced a typical case of hemorrhagic shock due
to traumatic bleeding, and the first clinical case of trau-
matic patient managed effectively by using Sonoclot. Ap-
propriate management and treatment of fluid and blood
transfusion resuscitation for a case of massive bleeding
as in our case is difficult. In the circumstances, severe
coagulopathy inevitably occur. The amount and type of
blood must be considered for estimating the degree of
surgical site bleeding. However, we also think that a useful
and appropriate parameter or guideline to support the
clinical decision for blood transfusion in a case of massive
hemorrhage is necessary. For example, arterial blood gas
analysis can be performed quickly. But arterial blood gas
analysis is useful as a guide for RBC transfusion. Also,
conventional blood coagulation tests for PT-INR, APTT,
and fibrinogen usually take much time for the indication
of FFP or platelet transfusion.
European guidelines for the management of bleeding
following major trauma were published in 2007 [4].
According to the guidelines, point-of care monitoring
of blood coagulation such as thrombelastometry might
be useful for more accurate targeting of therapy [5].
However, there are no guidelines for the treatment of
traumatic bleeding in Japan. Thus, we have to manage
and treat massive bleeding based on our own clinical
decision. Although it was thought that the viscoelastic
device as ROTEM and TEG was useful for trauma pa-
tients [6], no data on clinical effectiveness of Sonoclot
for traumatic bleeding was reported. Sonoclot analyzer
is always disposed in our operating room. And we
found that Sonoclot was useful as a guide for blood
transfusion during cardiac surgery and massive bleeding
in a clinical situation and in our clinical study (not yet
published). Thus, we thought that a Sonoclot analyzer is
very useful for management of coagulopathy and used a
Sonoclot analyzer in our case. The main benefits of this
device are as follows. Firstly, when we use the analyzer, we
can evaluate not only blood clotting function as the degree
of fibrin gel formation but also platelet function as clot re-
traction. Secondly, data can be obtained from the Sonoclot
analyzer after only 15 to 20 min. Thirdly, Sonoclot
analyzer can perform measurements using whole blood.
While, the disadvantage of Sonoclot compared to ROTEM
is that we cannot evaluate the exact cause for severe coag-
ulopathy, for example, intrinsic factor, extrinsic factor, or
fibrinogen. Therefore, when we would like to check an
exact cause for it, we should consider using not only
Sonoclot but also other device like ROTEM.
By the way, measurements of PT-INR and APTT are
performed using blood contained no platelet. Platelet
and coagulation factor are greatly related to the intra-
cellular collect blood coagulation system [7]. Therefore,
we think that the values of PT-INR and APTT are not
an appropriate signature for blood coagulation. In the
European guideline mentioned above [5], it was reported
that PT-INR and APTT alone should not be used to guide
hemostatic therapy. In fact, conventional blood coagulation
tests after the operation showed some coagulopathy. The
final SonACT and postoperative APTT were slightly pro-
longed. According to the past report [8], the cell-salvaged
transfusion may cause coagulopathy. The cell-salvaged
blood was transfused 2750 ml during the operation.








normal >15 × 104/μL
Before operation 1.6 59.3 65 2.6 × 104
After operation 1.31 52.5 136 7.4 × 104
Although conventional blood coagulation tests before the operation showed severe coagulation disorders, there were slightly improvements after operation








Point 1 581 1.5 0.5
Point 2 258 6.5 0.5
Point 3 193 11.3 3.2
Although all signatures of the Sonoclot analyzer, which is a point-of-care
monitor of clotting factor and platelet function, showed severe coagulopathy
(points 1 and 2), CR and PF, but not SonACT, were in normal ranges after the
bleeding had stopped (point 3)
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Although we should consider the amount of cell-salvaged
blood, CR and PF of Sonoclot signature was normal and
postoperative further bleeding did not occur. Therefore,
our results indicate that the value of Sonoclot may be reli-
able rather than PT-INR and APTT.
Conclusions
We experienced the first case of traumatic bleeding
managed effectively by using Sonoclot. Although the
further data is necessary, we suggest that the Sonoclot
analyzer may be useful for the management of severe
coagulopathy due to not only traumatic bleeding but
also massive bleeding of emergent situation.
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